Recent Headlines
Creative Biomart Releases New Recombinant Protein Products-Human MET Mutants
Creative Biomart announces that it has launched a series of new recombinant human MET mutants. - January 11, 2014 - Creative Biomart
International Polymer Solutions (IPS) Awarded ISO-9001:2008 Certification
ISO-9001:2008 Quality Certification granted to producer of plastic components for pharmaceutical, semiconductor, laboratory and other environments. International Polymer Solutions (IPS) is proud to announce their recent certification. - December 16, 2013 - International Polymer Solutions Inc.
American Regent, Inc. Takes Center Stage on The Balancing Act® Airing on Lifetime Talkshow
Make sure to tune in to The Balancing Act on December 11th and 18th at 7:00 am (ET/PT) as Blood specialist Dr. Lawrence Tim Goodnough, blood disease expert and Lynell D'Sylva, BSN, RN from American Regent explain what IDA is and introduce their innovative treatment option. - December 10, 2013 - American Regent, Inc.
Dr. Emil J. Haldey to Speak Before Medical Society of the State of New York
Dr. Emil J. Haldey, President of New York City-based HALDEY Pharmaceutical Compounding, will speak later this week before an audience of doctors at First District Branch of the Medical Society of the State of New York (MSSNY). MSSNY’s First Branch includes all five boroughs of New York... - November 20, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart Introduces New Elisa Kits to Offer More Convenient and Effective Solutions
In the early November, Creative Biomart decided to introduce new Elisa Kits which include Developmental proteins ELISA kits, Granzymes and perforins ELISA kits and Growth factors/hormones ELISA kits. - November 20, 2013 - Creative Biomart
Creative Biomart Decides to Pump $300 Million to Strengthen Biosimilar Cell Lines Production
Today on the annual department meeting, Creative BioMart announces that it plans to invest more than $300 million to strengthen its biosimilar cell lines production in global range. The domain sectors of Creative BioMart are recombinant proteins, antibodies and enzymes. Several years ago, the... - November 17, 2013 - Creative Biomart
Creative Biomart Announces Commercial Agreement for Services of Biosimilar Cell Lines Manufacturing
Creative Biomart announced today that it has signed a commercial agreement for contract manufacturing pharmaceutical biosimilar cell lines for a big pharma company. - November 10, 2013 - Creative Biomart
Creative Biomart Releases New Products in the Middle of Oct.
In the middle of Oct., Creative Biomart releases a new batch a products, including: Ÿ Recombinant Human MUSK, GST-tagged Ÿ Recombinant Human TIRAP, His-tagged Ÿ Native Mouse Hb Ÿ Recombinant Human NCAM2, GST-tagged Ÿ Recombinant Human NBPF15, His-tagged Ÿ Recombinant... - October 19, 2013 - Creative Biomart
HALDEY Pharmaceutical Compounding President to Address Brooklyn Physicians on Oct. 2
Dr. Emil J. Haldey will speak before an audience of doctors at the Medical Society of the County of Kings, in association with the Academy of Medicine of Brooklyn. - October 01, 2013 - HALDEY Pharmaceutical Compounding
Creative Biomart is Going to Sign Luciferase Supply Agreement with Kasain Laboratory
After a long-term contact and discussion, Creative Biomart finally agrees to sign a Luciferase supply agreement with Kasain Laboratory, especially Native Vibrio fischeri Luciferase (http://www.creativebiomart.net/description_390631_24.htm) until Kasain finishes its study projects. The official... - September 22, 2013 - Creative Biomart
International Polymer Solutions Debuts Corporate Video
Video provides overview of company products and services. - September 16, 2013 - International Polymer Solutions Inc.
International Polymer Solutions Launches New Website
TEQCOM and BECO websites merge to form new International Polymer Solutions site. - September 12, 2013 - International Polymer Solutions Inc.
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart
Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody
In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative Biomart
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart
Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users
In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative Biomart
Surgical Face Masks: AdvaCare Detects Rise in Global Demand
AdvaCare has detected a rise in global demand for its surgical face masks. This comes at the same time as recent headlines from Singapore which highlight the problem of pollution in South East Asia, including Indonesia and Malaysia. The market size for surgical face masks has expanded rapidly with individual consumers now becoming more conscious about their health. Medical supplies distributors, such as pharmacies and medical centers, should maintain ample stock of AdvaCare’s surgical face masks - August 01, 2013 - AdvaCare Pharmaceutical
Wescadia Group’s White Paper - Pursuing Growth: Optimizing Business Development Opportunities
Wescadia Group, a healthcare consultancy firm, announces the release of its white paper entitled “Pursuing Growth: Optimizing Business Development Opportunities.” - July 31, 2013 - Wescadia Group Pty Ltd
Creative Biomart Launched Novel Animal-free Recombinant Proteins for Stable Research
The novel animal-free protein production system is more efficient, fast, flexible and cheap compared to transgenic plants recombinant proteins production; the scaling-up compared with bio-reactors is simple and lineal. It doesn't have issues with inclusion bodies as E.coli. - June 28, 2013 - Creative Biomart
Blood Bag Market in Developing Countries (AdvaCare Pharma)
AdvaCare is currently on a campaign to find distributors for Blood Transfusion Bag (Blood Bags) in developing countries. - June 23, 2013 - AdvaCare Pharmaceutical
AdvaCare Announces Two New Products
AdvaCare is once again expanding its lists of products in an effort to better cater to patients and distributors. Sanitary pads and colostomy bags have been added to our existing array of medical supplies. - June 02, 2013 - AdvaCare Pharmaceutical
Creative Biomart Scientists Found That Shutdown Gene Arih2 May Treat Hepatitis
Arih2 was found within the sentinel dendritic cells of the immune system, which play a vital role in defending intruders. - May 31, 2013 - Creative Biomart
Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D
Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative Biomart
Novel Health Strategies Announces Publication of Annual and Recurring Strategy Overview on Emerging Life Sciences Market Trends
Novel Health Strategies Study Shows Oncology, Diabetes and Auto-Immune Indications Driving Growth of the Biotech Sector; More Products Facing Market Access Challenges. - January 24, 2013 - Novel Health Strategies
Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector
Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd
A Preview of AdvaCare’s Monthly Price Updates Newsletter
A Sneak Peak at 3 of Advacare's 7 Top Featured Products - December 16, 2012 - AdvaCare Pharmaceutical
Auto-Disable Syringes: Moving Towards Safer Vaccinations
It is undeniable that needles and syringes continue to be vital tools in numerous areas of healthcare and if used incorrectly, it can lead to often deadly diseases and infections. This happens most commonly with repeated needle use on multiple patients. A study carried by the World and Health... - December 09, 2012 - AdvaCare Pharmaceutical
Ameridose Sponsors Health Connect Partners' 2012 Fall Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce its sponsorship of Health Connect Partners’ 2012 Fall Hospital Pharmacy Conference, September 24-26 at the Hyatt Regency in Dallas, Texas. - September 19, 2012 - Ameridose, LLC
FyMed Demonstrates Superiority of FY101C Over Ibuprofen and Naproxen in the Treatment of Pain and Inflammation
FyMed, Inc. today announced results from comparative in-vivo studies of FY101C, its lead NSAID candidate, which demonstrated significant superiority to conventional NSAIDs in terms of efficacy and safety in the management of acute and chronic pain and inflammation. - July 25, 2012 - FyMed Inc
AdvaCare's New USFDA Approved Medical Disposable Product Line to be Introduced in June 2012
Medical Disposables and Supplies are AdvaCare’s fastest growing product line. - June 13, 2012 - AdvaCare Pharmaceutical
Ameridose Announces Agreement with HealthTrust
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to announce the signing of a new agreement for providing sterile admixing and repackaging services to HealthTrust Purchasing Group, L.P. (“HealthTrust”) members. - June 05, 2012 - Ameridose, LLC
Foamix Fortifies Its Patent Position in Mexico
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, announced today that the Company has obtained another granted patent in Mexico. - June 05, 2012 - Foamix Ltd
Nanocopoeia, an Innovative Leader in Particle-Based Therapeutics, is Pleased to Announce the Launch of Its Newly Redesigned Website
Nanocopoeia, Inc., a rapidly-growing nanotechnology company based in St. Paul, has launched its new corporate website, www.nanocopoeia.com. The new website provides detailed information on the applications and benefits of Nanocopoeia’s patented ElectroNanospray™ platform (ENS), a one... - June 01, 2012 - Nanocopoeia, Inc
Royal Care Pharmacy (RCP) Joins PCCA
RCP is pleased to announce PCCA membership. - May 31, 2012 - Royal Care Pharmacy Inc
Ameridose Announces Silver Sponsorship of USP 797 Compliance Study
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is delighted to be a silver sponsor for the 2nd annual USP <797> Compliance Study. The 2012 study will run from May 1 – June 30, collecting survey data from facilities engaged in sterile... - May 18, 2012 - Ameridose, LLC
Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry
Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc
Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium
Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc
The Pharma Compliance Group Announces Exclusive Sales Agreement with LearnSomething, Inc. for DEA Compliance Online Training
The Pharma Compliance Group (PCG) announce that it has signed an exclusive marketing and sales agreement with LearnSomething, Inc. to offer online training for the pharma industry to support DEA compliance of the CSA and CFR for pharmacists, pharmacy technicians and other DEA registrants. - May 07, 2012 - Pharma Compliance Group, LLC
Avomeen Analytical Services Opens Newly Renovated Pharmaceutical Research and Development Laboratory
Avomeen Analytical Services, an Ann Arbor, Michigan based independent testing laboratory has announced opening of newly renovated pharmaceutical research and development laboratories at its location at 6107 Jackson Rd Ann Arbor, Michigan. Avomeen’s pharmaceutical services include method... - May 05, 2012 - Avomeen Analytical Services
Ameridose Supports Pharmacy Leadership Forum
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is honored to sponsor the Executive Forum segment of Boston University School of Management’s 2012 Pharmacy Leadership Institute program. This year’s Executive Forum is titled... - May 01, 2012 - Ameridose, LLC
Foamix Obtains US Patent "Waterless Hydrophilic Foam" for Dermatological and Gynecological Drugs, Such as Antibiotics, Antifungals and Corticosteroids
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - April 27, 2012 - Foamix Ltd
Ameridose Sponsors Health Connect Partners 2012 Spring Hospital Pharmacy Conference
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to be a sponsor of the Health Connect Partners Spring Hospital Pharmacy Conference for a second consecutive year. The conference will take place from May 7-9, 2012 at the Hyatt Regency in... - April 26, 2012 - Ameridose, LLC
Ameridose Unveils Innovative First Quarter Sustainability Enhancements
Ameridose, LLC, the leading nationwide provider of sterile admixing services to hospital pharmacies, is pleased to share exciting sustainability news for the first quarter of 2012. Aiming for the ultimate in energy efficiency, Ameridose is currently in the process of installing a made-in-the-USA... - April 24, 2012 - Ameridose, LLC
EU Novel Foods Approved for Vitamin K2 Ingredient
Chrysalis Health & Beauty have announced the availability of Kappa K2Vital Vitamin K2 MK7 raw material for the UK and export markets following the successful EU Novel foods approval for this essential nutrient. - March 30, 2012 - Chrysalis Health & Beauty Business Solutions Limited
Foamix’s Minocycline Foam – 100% Effective in Impetigo Phase II Clinical Trial with No Side Effects. 80% Improved Significantly After 3 Days of Treatment.
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012 - Foamix Ltd
New Book Release
CGMP University inc of San Jose announced the release of two books: 1. How to design a Pharmaceutical Quality system. 2. Principles of design controls for medical device. - March 16, 2012 - cGMP UNIVERSITY INC.
Foamix Granted Comprehensive US Patent for PerFoam® – Ideal Foam Treatment for Head Lice and Scabies
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012 - Foamix Ltd
Foamix Obtains US Patent for Iodine Foam – Innovative Treatment for Heat Burns and Warfare Materials, as Well as Fungal and Bacterial Infection
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd
New Foamix US Patent: "Foamable Compositions, Kits and Methods for Hyperhidrosis" - First in Class Foam for Excessive Sweating
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012 - Foamix Ltd